METOCLOPRAMIDE
Aspiration Pneumonia
Mater Misericordiae University HospitalSmall moleculePhase 4 / ApprovedActive
BB
67/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 52/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Aspiration Pneumonia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
PROPRANOLOL Tang-Du Hospital | Phase 1 | CC |
Cromoglicic acid University of California, San Francisco | Phase 1 | CC |
Artiss Zuyderland Medisch Centrum | Phase 4 | NR |
Same molecule, other indications
METOCLOPRAMIDE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →